Exozymes (EXOZ) Other Accumulated Expenses (2023 - 2024)
Exozymes (EXOZ) has disclosed Other Accumulated Expenses for 2 consecutive years, with $255840.0 as the latest value for Q3 2024.
- Quarterly Other Accumulated Expenses changed N/A to $255840.0 in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $255840.0 through Sep 2024, changed N/A year-over-year, with the annual reading at $445128.0 for FY2023, N/A changed from the prior year.
- Other Accumulated Expenses for Q3 2024 was $255840.0 at Exozymes, down from $445128.0 in the prior quarter.
- The five-year high for Other Accumulated Expenses was $445128.0 in Q4 2023, with the low at $255840.0 in Q3 2024.